Amicus Therapeutics Inc. (FOLD)
NASDAQ: FOLD
· Real-Time Price · USD
7.40
0.28 (3.93%)
At close: Aug 15, 2025, 3:59 PM
7.41
0.13%
After-hours: Aug 15, 2025, 07:55 PM EDT
Amicus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 571.16M | 543.14M | 528.29M | 493.67M | 455.65M | 423.49M | 399.36M | 372.37M | 350.56M | 336.79M | 329.23M | 323.29M | 321.14M | 317.83M | 305.51M | 293.93M | 281.82M | 266.76M |
Cost of Revenue | 50.69M | 48.92M | 52.94M | 55.95M | 52.62M | 48.29M | 39.51M | 35.39M | 38.88M | 37.96M | 38.6M | 37.07M | 35.33M | 35.51M | 34.47M | 36.03M | 32.73M | 31.03M |
Gross Profit | 520.47M | 494.22M | 475.35M | 437.72M | 403.04M | 375.2M | 359.85M | 336.98M | 311.68M | 298.83M | 290.63M | 286.23M | 285.82M | 282.32M | 271.05M | 257.9M | 249.09M | 235.73M |
Operating Income | 14.16M | 38.6M | 24.88M | 11.26M | -27.42M | -61.25M | -77.21M | -114.26M | -130.51M | -172.27M | -204.54M | -235.94M | -245.07M | -223.29M | -206.43M | -199.12M | -209.49M | -222M |
Interest Income | 4.15M | 4.68M | 5.41M | 5.66M | 6.05M | 6.42M | 7.08M | 7.38M | 6.47M | 5.09M | 3.02M | 1.24M | 783K | 477K | 509K | 651K | 1.06M | 1.88M |
Pretax Income | -22.51M | -3.22M | -28.76M | -68.35M | -99.84M | -140.47M | -150.1M | -188.52M | -193.08M | -213.81M | -242.04M | -252.26M | -273.47M | -258.92M | -241.55M | -234.85M | -247.66M | -249.75M |
Net Income | -38.1M | -29.37M | -56.11M | -104.69M | -119.54M | -147.07M | -151.58M | -173.61M | -185.31M | -204.24M | -236.57M | -263.98M | -280.99M | -270.06M | -250.46M | -238.58M | -252.3M | -253.57M |
Selling & General & Admin | 338.14M | 327.18M | 323.38M | 306.95M | 297.5M | 289.34M | 275.27M | 259.31M | 240.93M | 228.88M | 213.04M | 216.37M | 215.2M | 204.1M | 192.71M | 178.79M | 170.54M | 162.92M |
Research & Development | 145.04M | 108.87M | 109.36M | 114.2M | 128.75M | 139.21M | 152.38M | 181.22M | 193.49M | 236.66M | 276.68M | 298.4M | 304.76M | 289.45M | 272.05M | 265.75M | 276.83M | 283.44M |
Other Expenses | 26.42M | 26.42M | 26.42M | n/a | n/a | -10.9M | -9.39M | -8.08M | -6.8M | 11.37M | 11.28M | 9.79M | 8.74M | 1.71M | -2.9M | -3.54M | -757K | 4.33M |
Operating Expenses | 502.75M | 455.62M | 450.48M | 421.15M | 426.24M | 430.76M | 431.37M | 445.55M | 440.73M | 470.98M | 495.06M | 520.32M | 525.75M | 499.56M | 470.97M | 451.78M | 455.58M | 455.04M |
Interest Expense | 1.63M | 48.62M | 49.6M | 50.47M | 50.76M | 50.74M | 50.15M | 48.42M | 45.05M | 40.82M | 37.12M | 34.19M | 32.73M | 32.63M | 32.47M | 32.58M | 31.2M | 26.69M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 553.45M | 504.54M | 503.42M | 482.41M | 478.86M | 479.05M | 470.87M | 480.94M | 479.6M | 508.94M | 533.66M | 557.38M | 561.08M | 535.07M | 505.43M | 487.81M | 488.32M | 486.07M |
Income Tax Expense | -2.17M | 26.16M | 27.35M | 36.34M | 25.95M | 12.86M | 7.74M | -8.66M | -7.76M | -9.57M | -5.47M | 11.72M | 7.52M | 11.13M | 8.91M | 3.73M | 4.64M | 3.82M |
Shares Outstanding (Basic) | 307.97M | 307.69M | 304.38M | 304.69M | 303.77M | 302.9M | 293.59M | 295.76M | 292.8M | 291.34M | 281.11M | 289.22M | 291.97M | 288.48M | 267.46M | 267.46M | 266.4M | 264.37M |
Shares Outstanding (Diluted) | 307.97M | 307.69M | 304.38M | 304.69M | 303.77M | 302.9M | 293.59M | 295.76M | 292.8M | 291.34M | 281.11M | 289.22M | 291.97M | 288.48M | 267.46M | 267.46M | 266.4M | 264.37M |
EPS (Basic) | -0.12 | -0.09 | -0.18 | -0.35 | -0.4 | -0.5 | -0.52 | -0.6 | -0.65 | -0.71 | -0.83 | -0.94 | -1.01 | -0.99 | -0.94 | -0.91 | -0.97 | -0.98 |
EPS (Diluted) | -0.12 | -0.09 | -0.18 | -0.35 | -0.4 | -0.5 | -0.52 | -0.6 | -0.65 | -0.71 | -0.83 | -0.94 | -1.01 | -0.99 | -0.94 | -0.91 | -0.97 | -0.98 |
EBITDA | -30.74M | 53.63M | 29.39M | -9.2M | -40.33M | -80.95M | -88.09M | -129.11M | -137.98M | -163.81M | -199.58M | -212.52M | -234.95M | -220.28M | -202.87M | -195.03M | -208.24M | -214.38M |
EBIT | 32.78M | 45.4M | 20.84M | -17.88M | -49.08M | -89.72M | -99.95M | -140.1M | -148.03M | -172.99M | -204.92M | -218.07M | -240.74M | -226.3M | -209.08M | -202.27M | -216.46M | -223.06M |
Depreciation & Amortization | 7.9M | 8.23M | 8.55M | 8.69M | 8.75M | 8.77M | 7.87M | 7M | 6.06M | 5.19M | 5.34M | 5.55M | 5.78M | 6.02M | 6.21M | 7.24M | 8.21M | 8.69M |